Fortrea Holdings Stock
Fortrea Holdings Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Anshul Thakral
- Employees
- 14,000
- Market cap
- $2.1 B
- IPO
- 20/06/2023
Fortrea Holdings Inc. functions as a global contract research organization within the Healthcare sector, concentrating on providing development services for biopharmaceutical products and medical devices. Headquartered in Durham, US, the company offers various engagement options, such as full-service provision,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Fortrea Holdings stock: price history
1D
-1.1%
1W
+7.9%
1M
+12.6%
6M
+116.7%
YTD
+30.4%
1Y
+136.2%
2Y
+14.9%
5Y
–
10Y
–
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~85% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Fortrea Holdings stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Fortrea Holdings Inc. operates as a global Contract Research Organization (CRO) supporting the clinical development of biopharmaceuticals and medical devices. The business model is organized into Clinical Services, which provide support for clinical pharmacology and development, and Enabling Services, which deliver technological solutions for clinical trial requirements such as randomization and drug supply management. The service portfolio spans Phase I through Phase IV studies as well as post-marketing services. The company offers flexible collaboration models, including full-service, Functional Service Provider (FSP) models, and hybrid arrangements. The client base comprises primarily companies from the pharmaceutical, biotechnology, and medical device industries.
- Revenue model
- Transactional
- Recurring revenue
- Low
- Pricing power
- Moderate
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about Fortrea Holdings
Analyst assessment of Fortrea Holdings
PRICE TARGET LOW
US$16.00
CONSENSUS
US$21.33
MEDIAN
US$22.50
PRICE TARGET HIGH
US$25.00
0
STRONG BUY
7
BUY
4
HOLD
1
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 15/10/2026
Fortrea Holdings stock metrics
P/E
-24.18
P/B
4.05
EV/EBITDA
38.03
RETURN ON EQUITY
-2.5%
NET MARGIN
-1.9%
DEBT/EQUITY
2.13
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.0%
FLOAT SHARES
94,145,957
AVG. DAILY VOLUME (30D)
1,680,836
Insider transactions (SEC)
Russell Carrie Elizabeth
Russell Carrie Elizabeth
Morais Mark A.
Morais Mark A.
Morais Mark A.
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Fortrea Holdings stock
What does Fortrea Holdings do?
Fortrea Holdings Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Anshul Thakral, the company employs around 14,000 people.
The IPO was on 20/06/2023; the stock trades on NASDAQ under the ticker FTRE.
What do analysts say about Fortrea Holdings stock?
12 analysts rate the stock, the consensus is Buy (as of 15/10/2026).
The average price target is US$21.33, ranging from US$16.00 to US$25.00, with a median of US$22.50.
This is an external assessment, not a statement by Market Jury.
When does Fortrea Holdings report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 85% stronger than usual.
Does Fortrea Holdings pay a dividend?
No, Fortrea Holdings currently does not pay a dividend.
Which stocks are comparable to Fortrea Holdings?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Fortrea Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Fortrea Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.